Viewing Study NCT02092467


Ignite Creation Date: 2025-12-25 @ 12:39 AM
Ignite Modification Date: 2026-02-21 @ 5:19 PM
Study NCT ID: NCT02092467
Status: COMPLETED
Last Update Posted: 2021-08-17
First Post: 2014-03-03
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Sponsor: Pfizer
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Arthritis, Rheumatoid View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Post-marketing View
None Phase 4 View
None Open-label View
None Safety Surveillance View
None CP690550 View
None Xeljanz View
None oral treatment View